Oncology & Genetic Marker Testing Reagent Supply
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract pertains to the supply of reagents for molecular testing of key genetic markers including BCR-ABL, Factor II, and Factor V Leiden mutations, specifically to support transplant monitoring and screening for hematologic disorders. These reagents are critical for accurate diagnostics and ongoing patient management in clinical settings requiring precise genetic detection. The work is to be performed in Seattle, Washington, with a delivery address of 98108, and the contract is classified under NAICS code 325412, indicating it falls within the pharmaceutical and medicine manufacturing sector. This is a subcontract issued by the Department of Veterans Affairs through its 260-NETWORK Contract Office 20, with a solicitation posting date of July 30, 2026, and a response deadline of August 6, 2027. The contract does not specify a set-aside type and lacks details on the point of contact or exact procurement requirements beyond the scope of reagent supply. The focus remains on ensuring a reliable, consistent supply chain of molecular diagnostics reagents essential for veterans’ hematologic and transplant care, with performance tied to maintaining product integrity and timely delivery to meet clinical needs.
General Info
Agency
NAICS
Place of Performance
Seattle, WA, 98108, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → 260-NETWORK Contract Office 20 (36C260)
Same awarding agency
